T. Kegel

发表

Phase II trial of capecitabine/irinotecan and capecitabine/oxaliplatin in advanced gastrointestinal cancers.

A. Grothey, K. Jordan, O. Kellner, 2004, Clinical colorectal cancer.

Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial

T. Gress, J. Schrader, D. Hörsch, 2021, BMC Cancer.

A New Chemoembolization Protocol in Refractory Liver Metastasis of Colorectal Cancer – a Feasibility Study

A. Grothey, W. Voigt, H. Schmoll, 2002, Oncology Research and Treatment.

[Practice guideline neuroendocrine tumors - AWMF-Reg. 021-27].

H. Amthauer, F. Lordick, A. Haug, 2018, Zeitschrift fur Gastroenterologie.

Changes in the diagnosis and treatment of patients with low grade lymphoma in Germany: years 2006–2009

M. Dreyling, C. Wendtner, C. Schmidt, 2015, Leukemia & lymphoma.

Lymphoma Changes in the Diagnosis and Treatment of Low Grade Lymphoma Patients in Germany : Years 2006-2009

C. Wendtner, R. Fischer, W. Pönisch, 2014 .

Phase 2 Trial of Docetaxel, Gemcitabine, and Oxaliplatin Combination Chemotherapy in Platinum- and Paclitaxel-Pretreated Epithelial Ovarian Cancer

A. Grothey, C. Thomssen, H. Koelbl, 2009, International Journal of Gynecologic Cancer.

Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer.

W. Voigt, H. Schmoll, K. Jordan, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Trabectedin: Supportive care strategies and safety profile.

J. Rüssel, C. Müller-Tidow, K. Jordan, 2015, Critical reviews in oncology/hematology.

Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma

W. Voigt, T. Mueller, H. Schmoll, 2005, Journal of Cancer Research and Clinical Oncology.

Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study

W. Voigt, D. Arnold, H. Wolf, 2010, Bone Marrow Transplantation.

Feasibility of a combination of high dose chemotherapy ifosfamide, carboplatin, etoposide (ICE) plus stem cells and bevacizumab in refractory sarcoma and germ cell tumors

H. Schmoll, K. Jordan, L. Mueller, 2005 .

Successful treatment of mediastinal lymphomatoid granulomatosis with rituximab monotherapy

A. Grothey, H. Wolf, H. Schmoll, 2005, European journal of haematology.

e8a2 BCR–ABL: more frequent than other atypical BCR–ABL variants?

P. Paschka, G. Martinelli, A. Hochhaus, 2005, Leukemia.

Neuroendocrine Tumors of the Bronchopulmonary System (Typical and Atypical Carcinoid Tumors): Current Strategies in Diagnosis and Treatment. Conclusions of an Expert Meeting February 2011 in Weimar, Germany

K. Darwiche, K. Schmid, R. Arnold, 2014, Oncology Research and Treatment.

Malignization of a vestibular schwannoma 13 years after radiation therapy

C. Strauss, D. Vordermark, S. Simmermacher, 2017, HNO.

Metastatic esophagogastric adenocarcinoma: trends in first-line treatment and predictive factors for the implementation of HER2 testing in clinical practice during the first year after trastuzumab market approval

R. Hofheinz, S. Al-Batran, D. Gencer, 2013, Journal of Cancer Research and Clinical Oncology.

Desmoplastic small round cell tumors: Multimodality treatment and new risk factors

S. Bielack, M. Münter, C. Kramm, 2019, Cancer medicine.

[Malignization of vestibular schwannoma 13 years after radiation therapy].

C. Strauss, D. Vordermark, S. Simmermacher, 2017, HNO.

Antiemetic Efficacy of an Oral Suspension of Granisetron plus Dexamethasone and Influence of Quality of Life on Risk for Nausea and Vomiting

A. Grothey, K. Jordan, C. Fibich, 2005, Oncology Research and Treatment.

Venous Access Ports: Frequency and Management of Complications in Oncology Patients

H. Wolf, A. Surov, K. Jordan, 2008, Oncology Research and Treatment.

Treatment of indolent lymphoma in Germany - results of a representative population-based survey.

Thomas Kegel, Martin Dreyling, Wolfgang Hiddemann, 2011, Clinical lymphoma, myeloma & leukemia.

The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (highdose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination

H. Schmoll, K. Jordan, P. Jahn, 2011, Bone Marrow Transplantation.

Treatment of Adolescents and Young Adults (AYA) with Cancer in a Multidisciplinary Setting: On the Way to a Highly Specialized AYA Unit

D. Körholz, H. Schmoll, T. Bernig, 2013, Klinische Pädiatrie.

Chemotherapy with Paclitaxel and Gemcitabine in Progressive Medullary and Thyroid Carcinoma of the Follicular Epithelium

W. Voigt, S. Petersenn, K. Mann, 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Recommendations for risk minimization when using Janus kinase inhibitors for the treatment of chronic inflammatory skin diseases

R. Grosse, T. Kegel, Johannes Wohlrab, 2023, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Treatment of malignant pericardial effusion with 32P-colloid

A. Grothey, W. Dempke, W. Voigt, 1999, British Journal of Cancer.

S2k-Leitlinie Neuroendokrine Tumore

H. Amthauer, F. Lordick, A. Haug, 2018, Zeitschrift für Gastroenterologie.

Neuroendocrine Tumors of the Bronchopulmonary System (Typical and Atypical Carcinoid Tumors): Current Strategies in Diagnosis and Treatment. Conclusions of an Expert Meeting February 2011 in Weimar, Germany

K. Darwiche, K. Schmid, R. Arnold, 2014, Oncology Research and Treatment.